These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 32336474)
1. Chronotherapy for reduction of cardiovascular risk. Hermida RC; Hermida-Ayala RG; Smolensky M Med Clin (Barc); 2020 Jun; 154(12):505-511. PubMed ID: 32336474 [TBL] [Abstract][Full Text] [Related]
2. [2013 Ambulatory blood pressure monitoring recommendations for the diagnosis of adult hypertension, assessment of cardiovascular and other hypertension-associated risk, and attainment of therapeutic goals (summary). Joint recommendations from the International Society for Chronobiology (ISC), American Association of Medical Chronobiology and Chronotherapeutics (AAMCC), Spanish Society of Applied Chronobiology, Chronotherapy, and Vascular Risk (SECAC), Spanish Society of Atherosclerosis (SEA), and Romanian Society of Internal Medicine (RSIM)]. Hermida RC; Smolensky MH; Ayala DE; Portaluppi F; Crespo JJ; Fabbian F; Haus E; Manfredini R; Mojón A; Moyá A; Piñeiro L; Ríos MT; Otero A; Balan H; Fernández JR Clin Investig Arterioscler; 2013; 25(2):74-82. PubMed ID: 23849214 [TBL] [Abstract][Full Text] [Related]
3. Sleep-time blood pressure: Unique sensitive prognostic marker of vascular risk and therapeutic target for prevention. Hermida RC; Ayala DE; Smolensky MH; Fernández JR; Mojón A; Portaluppi F Sleep Med Rev; 2017 Jun; 33():17-27. PubMed ID: 27316324 [TBL] [Abstract][Full Text] [Related]
4. Cardiovascular disease risk stratification by the Framigham score is markedly improved by ambulatory compared with office blood pressure. Hermida RC; Ayala DE; Mojón A; Smolensky MH; Crespo JJ; Otero A; Domínguez-Sardiña M; Moyá A; Ríos MT; Castiñeira MC; Callejas PA; Pousa L; Sineiro E; Salgado JL; Durán C; Sánchez JJ; Fernández JR Rev Esp Cardiol (Engl Ed); 2021 Nov; 74(11):953-961. PubMed ID: 32950423 [TBL] [Abstract][Full Text] [Related]
5. Sleep-time ambulatory blood pressure as a prognostic marker of vascular and other risks and therapeutic target for prevention by hypertension chronotherapy: Rationale and design of the Hygia Project. Hermida RC Chronobiol Int; 2016; 33(7):906-36. PubMed ID: 27221952 [TBL] [Abstract][Full Text] [Related]
6. Chronotherapy with conventional blood pressure medications improves management of hypertension and reduces cardiovascular and stroke risks. Hermida RC; Ayala DE; Smolensky MH; Fernández JR; Mojón A; Portaluppi F Hypertens Res; 2016 May; 39(5):277-92. PubMed ID: 26657008 [TBL] [Abstract][Full Text] [Related]
7. Elevated asleep blood pressure and non-dipper 24h patterning best predict risk for heart failure that can be averted by bedtime hypertension chronotherapy: A review of the published literature. Hermida RC; Mojón A; Fernández JR; Hermida-Ayala RG; Crespo JJ; Ríos MT; Domínguez-Sardiña M; Otero A; Smolensky MH Chronobiol Int; 2023 Jan; 40(1):63-82. PubMed ID: 34190016 [TBL] [Abstract][Full Text] [Related]
8. Hypertension: New perspective on its definition and clinical management by bedtime therapy substantially reduces cardiovascular disease risk. Hermida RC; Ayala DE; Fernández JR; Mojón A; Smolensky MH Eur J Clin Invest; 2018 May; 48(5):e12909. PubMed ID: 29423914 [TBL] [Abstract][Full Text] [Related]
9. Ambulatory blood pressure monitoring in the prediction of cardiovascular events and effects of chronotherapy: rationale and design of the MAPEC study. Hermida RC Chronobiol Int; 2007; 24(4):749-75. PubMed ID: 17701685 [TBL] [Abstract][Full Text] [Related]
11. Ambulatory blood pressure monitoring in diabetes for the assessment and control of vascular risk. Hermida RC; Moyá A; Ayala DE Endocrinol Nutr; 2015 Oct; 62(8):400-10. PubMed ID: 26404624 [TBL] [Abstract][Full Text] [Related]
12. Cardiovascular risk of essential hypertension: influence of class, number, and treatment-time regimen of hypertension medications. Hermida RC; Ayala DE; Mojón A; Fernández JR Chronobiol Int; 2013 Mar; 30(1-2):315-27. PubMed ID: 23181712 [TBL] [Abstract][Full Text] [Related]
15. New perspectives on the definition, diagnosis, and treatment of true arterial hypertension. Hermida RC; Smolensky MH; Mojón A; Crespo JJ; Ríos MT; Domínguez-Sardiña M; Otero A; Fernández JR Expert Opin Pharmacother; 2020 Jul; 21(10):1167-1178. PubMed ID: 32543325 [TBL] [Abstract][Full Text] [Related]
16. Role of time-of-day of hypertension treatment on the J-shaped relationship between blood pressure and cardiovascular risk. Hermida RC; Ayala DE; Mojón A; Fernández JR Chronobiol Int; 2013 Mar; 30(1-2):328-39. PubMed ID: 23181738 [TBL] [Abstract][Full Text] [Related]
17. Prevalence and clinical characteristics of isolated-office and true resistant hypertension determined by ambulatory blood pressure monitoring. Ríos MT; Domínguez-Sardiña M; Ayala DE; Gomara S; Sineiro E; Pousa L; Callejas PA; Fontao MJ; Fernández JR; Hermida RC; Chronobiol Int; 2013 Mar; 30(1-2):207-20. PubMed ID: 23077975 [TBL] [Abstract][Full Text] [Related]
18. Ambulatory Blood Pressure Monitoring (ABPM) as the reference standard for diagnosis of hypertension and assessment of vascular risk in adults. Hermida RC; Smolensky MH; Ayala DE; Portaluppi F Chronobiol Int; 2015; 32(10):1329-42. PubMed ID: 26587588 [TBL] [Abstract][Full Text] [Related]
19. Sleep-time blood pressure: prognostic value and relevance as a therapeutic target for cardiovascular risk reduction. Hermida RC; Ayala DE; Fernández JR; Mojón A Chronobiol Int; 2013 Mar; 30(1-2):68-86. PubMed ID: 23181592 [TBL] [Abstract][Full Text] [Related]
20. Bedtime Chronotherapy with Conventional Hypertension Medications to Target Increased Asleep Blood Pressure Results in Markedly Better Chronoprevention of Cardiovascular and Other Risks than Customary On-awakening Therapy. Smolensky MH; Hermida RC; Ayala DE; Mojón A; Fernández JR Heart Fail Clin; 2017 Oct; 13(4):775-792. PubMed ID: 28865784 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]